Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

Who should be vaccinated against HPV?

Canfell K.

BMJ. 2015 May 12;350:h2244. doi: 10.1136/bmj.h2244. No abstract available.

PMID:
25985329
2.

The Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): Rationale and design of an unmatched "case-spouse control" study of over 10,000 participants in New South Wales, Australia.

Sitas F, Yap S, Egger S, Christian K, Hodgkinson V, Barton M, Banks E, Canfell K, O'Connell DL, Nair-Shalliker V.

Cancer Epidemiol. 2015 Apr 16. pii: S1877-7821(15)00073-9. doi: 10.1016/j.canep.2015.03.006. [Epub ahead of print]

PMID:
25892705
3.

Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study.

Canfell K, Egger S, Velentzis LS, Brown JD, O'Connell DL, Banks E, Sitas F.

Vaccine. 2015 May 11;33(20):2387-94. doi: 10.1016/j.vaccine.2015.01.024. Epub 2015 Apr 3.

4.

Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.

Velentzis LS, Sitas F, O'Connell DL, Darlington-Brown J, Egger S, Sinha R, Banks E, Frazer IH, Canfell K.

BMC Infect Dis. 2014 Dec 21;14:3861. doi: 10.1186/s12879-014-0676-z.

5.

A survey of population-based utility scores for cervical cancer prevention.

Simonella L, Howard K, Canfell K.

BMC Res Notes. 2014 Dec 11;7:899. doi: 10.1186/1756-0500-7-899.

6.
7.
8.

Incremental benefits of male HPV vaccination: accounting for inequality in population uptake.

Smith MA, Canfell K.

PLoS One. 2014 Aug 4;9(8):e101048. doi: 10.1371/journal.pone.0101048. eCollection 2014.

9.

Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program.

Pearson AL, Kvizhinadze G, Wilson N, Smith M, Canfell K, Blakely T.

BMC Infect Dis. 2014 Jun 26;14:351. doi: 10.1186/1471-2334-14-351.

10.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

11.

Testing previous model predictions against new data on human papillomavirus vaccination program outcomes.

Smith MA, Canfell K.

BMC Res Notes. 2014 Feb 25;7:109. doi: 10.1186/1756-0500-7-109.

12.

High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.

Sultana F, English DR, Simpson JA, Canfell K, Gertig DM, Saville M.

Int J Cancer. 2014 Sep 1;135(5):1213-9. doi: 10.1002/ijc.28756. Epub 2014 Mar 13.

PMID:
24488882
13.
14.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 31;31 Suppl 7:H1-31. doi: 10.1016/j.vaccine.2013.10.003.

PMID:
24332295
15.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 30;31 Suppl 6:G1-31. doi: 10.1016/j.vaccine.2013.10.002. Review.

PMID:
24331817
16.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 29;31 Suppl 5:F1-31. doi: 10.1016/j.vaccine.2013.10.001. Review.

PMID:
24331745
17.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Nov 22;31 Suppl 8:I1-31. doi: 10.1016/j.vaccine.2013.07.026. Review.

18.

Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007.

Sitas F, Gibberd A, Kahn C, Weber MF, Chiew M, Supramaniam R, Velentzis L, Nickson C, Smith DP, O'Connell D, Smith MA, Armstrong K, Yu XQ, Canfell K, Robotin M, Feletto E, Penman A.

Cancer Epidemiol. 2013 Dec;37(6):780-7. doi: 10.1016/j.canep.2013.09.010. Epub 2013 Oct 30.

PMID:
24183782
19.

Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA).

Greuter MJ, Xu XM, Lew JB, Dekker E, Kuipers EJ, Canfell K, Meijer GA, Coupé VM.

Risk Anal. 2014 May;34(5):889-910. doi: 10.1111/risa.12137. Epub 2013 Oct 31.

PMID:
24172539
20.

Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model.

Shafer LA, Jeffrey I, Elias B, Shearer B, Canfell K, Kliewer E.

Vaccine. 2013 Oct 1;31(42):4848-55. doi: 10.1016/j.vaccine.2013.07.073. Epub 2013 Aug 9.

PMID:
23933332
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk